Skip to main content

Advertisement

Log in

Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study was to evaluate the diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in northern Chinese Han patients with rheumatoid arthritis (RA) and its correlation with disease activity. Clinical data and serum samples were collected from 112 RA patients and 55 non-RA patients. Statistical analyses of the correlations among anti-CCP antibodies, other serological markers, and the RA patients’ clinical characteristics were performed using SPSS 11.5 software. Anti-CCP antibodies were detected in 77.7% of all RA patients and 80.4% of the RA patients with a disease duration of 3 years or less. The combined diagnosis using high titer anti-CCP antibodies (≥100 RU/ml) with a concomitant positive rheumatoid factor (RF) test exhibited the greatest diagnostic specificity; it achieved 87.9% for all RA patients and 90.1% for the patients with disease duration of three years or less. Moreover, anti-CCP antibodies showed medium correlations to the RA patient’s serum RF titer (r = 0.560, P < 0.001) and disease activity (DAS28 score; r = 0.404, P < 0.001). Compared with the patients with low anti-CCP antibody titers (<100 RU/ml), patients with high anti-CCP antibody titers showed higher RF titers, worse DAS28 scores, and severe morning stiffness (P < 0.01). This study suggests that anti-CCP antibodies can be used for RA diagnosis and disease activity evaluation for northern Han Chinese patients. A combined diagnosis using both high titers of anti-CCP antibodies (≥100 RU/ml) and a positive RF test markedly improves RA diagnostic specificity. Patients’ DAS28 scores rise and morning stiffness intensifies with increasing anti-CCP antibody titers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Mediwake R, Isenberg DA, Schellekens GA et al (2001) Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 60:67–68

    Article  CAS  PubMed  Google Scholar 

  2. Silveira IG, Burlingame RW, von Mühlen CA et al (2007) Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol 26:1883–1889

    Article  CAS  PubMed  Google Scholar 

  3. Bukhari M, Thomson W, Naseem H et al (2007) The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 56:2929–2935

    Article  CAS  PubMed  Google Scholar 

  4. Yang CL, Zhou YR, Zhou F et al (2007) Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis. Nan Fang Yi Ke Da Xue Xue Bao 27:1277–1279

    CAS  PubMed  Google Scholar 

  5. Zeng X, Ai M, Tian X et al (2003) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Rheumatol 30:1451–1455

    CAS  PubMed  Google Scholar 

  6. Wu Y, Xu Y, Sun Y et al (2008) Association between the serotonin 1A receptor C(-1019)G polymorphism and major depressive disorder in the northern Han ethnic group in China. Chin Med J 121:874–876

    CAS  PubMed  Google Scholar 

  7. DAS-Score.NL. [http://www.das-score.nl/www.das-score.nl/index.html]

  8. Mimori T (2005) Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Intern Med 44:1112–1126

    Article  Google Scholar 

  9. Kwok JS, Hui KH, Lee TL et al (2005) Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand J Rheumatol 34:359–366

    Article  CAS  PubMed  Google Scholar 

  10. Barnetche T, Constantin A, Cantagrel A et al (2008) New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res Ther 10:R26

    Article  PubMed  Google Scholar 

  11. Senkpiehl I, Marget M, Wedler M et al (2005) HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis. Int Arch Allergy Immunol 137:315–318

    Article  CAS  PubMed  Google Scholar 

  12. van Gaalen FA, van Aken J, Huizinga TWJ et al (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influence the severity of rheumatoid arthritis. Arthritis Rheum 50:2113–2121

    Article  PubMed  Google Scholar 

  13. Fan LY, Zong M, Lu TB et al (2009) Association of the PADI4 gene polymorphism and HLA-DRB1 shared epitope alleles with rheumatoid arthritis. Zhong hua Yi Xue Yi Chuan Xue Za Zhi 26:57–61

    CAS  Google Scholar 

  14. Xue Y, Zhang J, Chen YM et al (2008) The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Scand J Rheumatol 37:183–187

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the National High Technology Research and Development Program of China (2006AA02Z4B1) and the National Natural Science Foundation of China (NSFC) (J0730858, J0830834).

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhang Fengmin.

Additional information

Li Hui and Song Wuqi equally contributed to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hui, L., Wuqi, S., Yang, L. et al. Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29, 413–417 (2010). https://doi.org/10.1007/s10067-009-1337-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1337-2

Keywords

Navigation